TY - JOUR
T1 - Sudden cardiac death following liver transplantation
T2 - Incidence, trends and risk predictors
AU - Koshy, Anoop N.
AU - Gow, Paul J.
AU - Han, Hui Chen
AU - Teh, Andrew W.
AU - Lim, Han S.
AU - Testro, Adam
AU - Jones, Robert
AU - Farouque, Omar
PY - 2021/3/15
Y1 - 2021/3/15
N2 - Background: Cardiovascular events are a leading cause of mortality following liver transplantation (LT). Although a preponderance of sudden cardiac death (SCD) in this population has been reported, there is a paucity of data evaluating the incidence, timing and predictors of SCD following LT. Methods: Using the prospectively collected Australian and New Zealand Liver Transplant Registry, a cohort study of all adult LTs from 1985 to 2017 was performed to ascertain the incidence and predictors of SCD. Recipient cause of death was adjudicated by an interdisciplinary panel. Results: 4265 LT patients were followed-up for 37,409 person-years. SCD was the leading mode of cardiovascular death with an incidence rate of 165 per 100,000 person-years. There was a significant increase in the hazard of SCD in the contemporary (1996–2017) vs early era (1985–1995) (hazard ratio [HR] 2.42, 95%CI 1.10–5.40; p = 0.02). On Cox regression after adjusting for significant univariate predictors including age, coronary artery disease and non-alcoholic steatohepatitis, pre-transplant diabetes was the only independent predictor of SCD (HR 2.5 95%CI 1.1–6.0). Conclusion: SCD is the leading mode of cardiovascular cause-specific mortality following LT and diabetes was associated with a two-fold higher risk for its occurrence. Given the escalating cardiovascular risk factor profile of LT candidates, targeted therapies especially in patients with diabetes are needed to mitigate risk of post-transplant SCD.
AB - Background: Cardiovascular events are a leading cause of mortality following liver transplantation (LT). Although a preponderance of sudden cardiac death (SCD) in this population has been reported, there is a paucity of data evaluating the incidence, timing and predictors of SCD following LT. Methods: Using the prospectively collected Australian and New Zealand Liver Transplant Registry, a cohort study of all adult LTs from 1985 to 2017 was performed to ascertain the incidence and predictors of SCD. Recipient cause of death was adjudicated by an interdisciplinary panel. Results: 4265 LT patients were followed-up for 37,409 person-years. SCD was the leading mode of cardiovascular death with an incidence rate of 165 per 100,000 person-years. There was a significant increase in the hazard of SCD in the contemporary (1996–2017) vs early era (1985–1995) (hazard ratio [HR] 2.42, 95%CI 1.10–5.40; p = 0.02). On Cox regression after adjusting for significant univariate predictors including age, coronary artery disease and non-alcoholic steatohepatitis, pre-transplant diabetes was the only independent predictor of SCD (HR 2.5 95%CI 1.1–6.0). Conclusion: SCD is the leading mode of cardiovascular cause-specific mortality following LT and diabetes was associated with a two-fold higher risk for its occurrence. Given the escalating cardiovascular risk factor profile of LT candidates, targeted therapies especially in patients with diabetes are needed to mitigate risk of post-transplant SCD.
KW - Cardiac arrest
KW - Cardiovascular mortality
KW - Liver cirrhosis
KW - Liver transplantation
KW - Non-alcoholic fatty liver disease
KW - Sudden cardiac death
UR - http://www.scopus.com/inward/record.url?scp=85097784662&partnerID=8YFLogxK
U2 - 10.1016/j.ijcard.2020.11.038
DO - 10.1016/j.ijcard.2020.11.038
M3 - Article
C2 - 33253736
AN - SCOPUS:85097784662
SN - 0167-5273
VL - 327
SP - 171
EP - 174
JO - International Journal of Cardiology
JF - International Journal of Cardiology
ER -